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Abstract
Background: Asthma is an important focus for pediatric health research as management of asthma symptoms is a significant
challenge, and morbidity and mortality among youths with asthma remain prevalent. Treatment guidelines for asthma recommend
a written asthma action plan (WAAP) that summarizes individualized instructions for daily medication use. However, WAAPs
are typically written at a seventh- to ninth-grade reading level, which can be a barrier to young people in understanding their
treatment, having confidence in using a WAAP, and engaging with asthma education.
Objective: Utilizing a feasibility and pilot randomized controlled trial (RCT) design, the objective of the Take Action for Asthma
Control study is to test a symptom-based, computer-generated pictorial asthma action plan (PAAP) in comparison with a standard
WAAP and assess the feasibility and acceptability of the asthma action plan (AAP) intervention and study procedures. The study
has 3 aims: (1) estimate the effect sizes of PAAPs compared with WAAPs on outcomes (eg, AAP knowledge and medication
adherence), (2) evaluate feasibility and acceptability of AAP intervention and RCT procedures from the perspectives of key
stakeholders, and (3) establish whether parent and youth literacy levels are associated with treatment outcomes.
Methods: This feasibility and pilot RCT is a block randomized, 2-arm, parallel-group clinical trial, lasting 6 months in duration.
At baseline, participants will be randomly assigned to receive a PAAP or WAAP generated for them and reviewed with them by
their asthma physician. Study procedures will take place over 4 separate time points: a baseline clinic appointment, 1-month
telephone follow-up, and 3- and 6-month clinic-based follow-ups. At each time point, data will be collected related to the main
outcomes: AAP knowledge, AAP satisfaction, asthma control, pulmonary function, and adherence to daily asthma medication.
A sample size of up to 60 participants (aged 8-17 years) will be recruited. Feasibility and acceptability data will be collected via
one-to-one qualitative interviews with providers involved in the study and a subgroup of families that participate in the study.
Results: Recruitment and data collection began in May 2017 and were completed in October 2018.
Conclusions: This pilot and feasibility study will test the potential efficacy, feasibility, and acceptability of an AAP intervention
and study procedures. The findings will inform the design and delivery of a future definitive trial to assess the efficacy of PAAPs
versus WAAPs in supporting asthma self-management among children and adolescents.
International Registered Report Identifier (IRRID): DERR1-10.2196/11733
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Introduction
Background
Asthma affects over 10 million children and adolescents in the
United States [1]. Suboptimal asthma management is associated
with morbidity (eg, school absences and asthma attacks) [2]
and even mortality [1]. Effective asthma management requires
that both preventive and rescue medications are taken at the
appropriate times and a clear understanding of when to seek
emergency care. Current best practices for asthma management
include administration of an asthma action plan (AAP), and
providing specific, individualized instruction to people with
asthma and caregivers regarding their daily treatment regimen
[3]. The use of written asthma action plans (WAAPs) can be
associated with a number of improved health outcomes,
including fewer hospitalizations and improved adherence to
medications [4,5]. However, possible literacy deficits [6], lack
of self-efficacy in relation to using an AAP [7], and insufficient
asthma education [8,9] are important and significant barriers to
both providers and families accepting and using AAPs
effectively.
Given that most WAAPs consist of densely presented text
typically written at a seventh- to ninth-grade reading level [10],
their utility could be reduced for people with literacy concerns.
Low parental literacy, which is often reported in rural
populations [11-13], is associated with significantly poorer
outcomes in children with asthma, such as an increased number
of emergency department visits and school absences [13].
Moreover, although children as young as 9 years old are
principally responsible for their asthma medication use [14],
young people may not be engaged in asthma education during
clinic visits, negatively impacting the development of their
asthma literacy and self-management skills [8]. A recent report
found that in the United States, only 50.8% of young people
under the age of 18 years receive an AAP [7]. Concerns related
to the accessibility of AAPs, the literacy levels, and the
responsibility placed on young people to manage their asthma
provide a rationale for developing a simplified and
individualized AAP that can facilitate engaging young people
and families in asthma education and in daily asthma
management.
Visual tools for communicating health-related information (eg,
details about a diagnosis and instructions for treatment) can
improve comprehension, satisfaction with information,
self-management, and provider-patient engagement [15-17].
Recent AAP research has integrated the use of images with
different amounts of supporting text [18,19] or mobile apps [20]
to communicate asthma treatment plans. However, the focus of
this AAP research has been to develop pictorial asthma action
plans (PAAPs) and electronic AAPs [21,22] and to evaluate the
feasibility and acceptability of their use [20,23]. Existing
research has focused on the perspectives and behaviors of
parents with little integration of the perspectives of young people
[19]. The impact of PAAPs or electronic AAPs on the
comprehension of asthma treatment among children has not
been investigated to date, nor has the impact of PAAPs on parent
or youth asthma management behavior.
Study Objective
This protocol describes the final phase in a 2-phase study, called
the Take Action for Asthma Control (TAAC) study, which aims
to assess the feasibility, acceptability, and preliminary efficacy
of a symptom-based, computer-generated PAAP for supporting
pediatric asthma management relative to a standard text-based
WAAP. In the first phase, PAAP software was developed in
consultation with young people with asthma, their parents and
asthma providers, and a health technology company [24]. This
software enables providers to generate simplified and tailored
PAAPs that reflect the patient’s asthma treatment regimen.
PAAPs primarily comprise graphics and images, with minimal
words or phrases.
Assessing feasibility and acceptability of interventions in health
care settings will ensure that important factors related to
intervention design and study procedures are explored and
optimized before implementing a definitive randomized
controlled trial (RCT) [25]. Moreover, this focus during the
intervention development and pilot testing phases is now
generally considered a prerequisite for successful
implementation of interventions into clinical practice [26]. On
the basis of guidance for conducting pilot and feasibility studies
[27,25], the approach to data collection in this study was
designed to answer pertinent questions ahead of a future
definitive trial. Thus, feasibility-related questions are concerned
with understanding whether or not a future trial and routine use
of PAAPs in practice may be possible. For example, fit of the
study activities within the flow of asthma clinics is one of our
feasibility outcomes. Acceptability-related questions will address
the asthma education preferences of providers and families, and
the appeal and usability of PAAPs from the perspectives of
families are among the acceptability outcomes in this study.
A mixed-methods approach to data collection and analysis will
be used based on the current guidelines for the development of
effective behavior change interventions [28]. Using a pilot RCT
design, the aims of this study are threefold: (1) assess initial
evidence for the efficacy of PAAPs in comparison with WAAPs
for improving pediatric asthma management and outcomes (ie,
child and caregiver knowledge of treatment plan, AAP
satisfaction, adherence to daily controller medication, symptom
control, and lung function), resulting in robust effect size
estimates ahead of a future definitive RCT; (2) evaluate the
feasibility and acceptability of the PAAP software, PAAPs, and
study procedures; and (3) identify whether parent health literacy
and youth literacy levels are associated with outcomes.
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Methods
The study protocol, personnel, and materials have been reviewed
and approved by the Institutional Review Board at West Virginia
University (WVU).
Study Design and Sample
This study is taking place in subspecialty clinics
(asthma/allergy/pulmonology) across 3 locations affiliated with
WVU Medicine, Department of Pediatrics. A sample of 60
children and adolescents with asthma (aged 8-17 years) and
parents or caregivers or legal guardian (hereon referred to as
parent) will be recruited. Participants will be block randomized
(age: 8-12 and 13-17 years; physician-determined asthma
severity: mild or moderate to severe) to 1 of the 2 groups: a
PAAP group or a WAAP group. Random group assignment is
identified through selection of an envelope from sets of
envelopes arranged into the randomization blocks. Group
assignment is concealed until the family has completed the
informed consent process. Data will be collected at baseline
(enrollment and intervention), with follow-up 1, 3, and 6 months
later.
The inclusion criteria for the participants are as follows: (1)
aged 8-17 years, (2) have a clinical diagnosis of persistent
asthma, (3) have a prescription for a daily controller inhaler
compatible with an adherence monitoring electronic sensor (ie,
Qvar HFA (TEVA), Dulera HFA (Merck), Advair [HFA and
Diskus] (GSK), or Flovent [HFA and Diskus] (GSK), (4) have
never received an AAP in the past, and (5) do not have a
disability or cognitive impairment that would prevent them from
completing the study procedures. Eligible participants must also
match at least one of the following supplemental criteria: (1)
newly diagnosed with persistent asthma, (2) asthma control is
suboptimal (eg, child is using his or her rescue inhaler often),
or (3) physician plans to make a change to the patient’s asthma
treatment plan.
Potentially eligible families will be identified through 2
pathways: (1) clinic staff will identify potential participants
through the electronic medical record (EMR) system and share
clinic appointment details with the research team or (2) through
a filter based on eligibility criteria applied to EMR lists
associated with clinics. Families identified this way will receive
a brief email message through the EMR system, introducing
them to the study and providing contact details for the research
team. Families who do not have an active email account as part
of the EMR system will receive a phone call. Interested families
who are not already receiving care in one of the study’s allergy
or asthma specialty clinics can be referred by their physician if
a referral is deemed appropriate.
A research team member will call all families in advance of
their clinic appointment to introduce or reintroduce the study
so that they can plan to have enough time to stay to complete
the baseline appointment, which lasts approximately 90 min.
Study Intervention
The TAAC intervention involves an individually tailored AAP
(WAAP or PAAP) summarizing each participant’s asthma
treatment plan. On the basis of the National Health, Lung &
Blood Institute (NHLBI) guidelines for managing persistent
asthma [3] and the patient’s prescribed asthma treatment,
physicians will populate AAPs according to 3 colored zones
that describe treatment instructions in response to asthma
symptoms characteristic of each zone: (1) green zone comprises
daily management options when no symptoms are present; (2)
yellow zone presents options for managing distressing asthma
symptoms, including wheezing and chest tightness; and (3) red
zone outlines options for managing highly distressing, even
life-threatening asthma symptoms, such as severe shortness of
breath. PAAPs will be generated using the PAAP software and
printed onto a single page with a color printer, whereas the
NHLBI WAAP template [29] will be completed by hand and
photocopied for participants. Multiple copies of the AAP will
be given to each family, and families will be encouraged to
place the copies in convenient locations (eg, refrigerator) for
prompting asthma management. The same individually tailored
asthma management guidance (via AAP) is delivered to
participants, regardless of the assigned intervention group. To
ensure AAP review sessions are uniform across participants,
physicians are encouraged to maintain consistency in reviewing
details of asthma care plans, regardless of participant group
assignment, thereby delivering sessions that are equivalent in
length. All AAP review sessions are audio recorded, and 20%
(approximately 12 recordings) of them will be randomly selected
for evaluation by an independent researcher to assess
intervention fidelity and uniformity across groups.
The PAAP software is designed to enable providers to quickly
and easily generate a PAAP that is tailored to the characteristics
(ie, gender and ethnicity) and asthma treatment plans (eg, daily
controller inhaler type) of each participant. Physicians will
generate the PAAP by responding to questions organized by
zone (green, yellow, and red), and each question is followed by
a drop-down menu of options. PAAPs comprise 3 horizontal
banners for the green, yellow, and red zone treatment
instructions (see Figure 1). Each zone begins with an avatar
representing the particular child (ie, gender and race and
ethnicity) and provides a visual cue for the level of distress and
types of symptoms associated with each zone. A child’s favorite
sport or physical activity is incorporated into the PAAP to
communicate a pre-exercise prescription, if relevant. PAAPs
contain various images (eg, inhalers, a spacer, and a cell phone)
and symbols (eg, sun to denote the time of day) for prompts as
well as a small amount of basic text and numerical information
to communicate treatment instructions. The PAAP software
program was designed so that it does not have the capability to
store any Protected Health Information data related to individual
participants.
Physician training to generate AAPs using the PAAP software
will occur over a 30-minute session with the project coordinator.
During these sessions, a written step-by-step guide will be
provided to the physicians and they will be introduced to the
software, several sample PAAPs will be generated, and issues
or questions will be discussed.
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Figure 1. Example of personalized pictorial asthma action plan.
The NHLBI WAAP template [30] was chosen because the
NHLBI is the principal source of up-to-date and evidence-based
guidelines related to asthma management in the United States.
The treatment options available to providers in the PAAP
software were selected based on the NHLBI guidelines [3]. In
addition, the horizontal format of the NHLBI WAAP mirrors
the format of the PAAP. The WAAP template enables providers
to communicate the same information as that provided through
the PAAP software. However, the WAAP consists of text and
numerical content only, with no images included.
Intervention Components
The TAAC intervention comprises 5 behavior change techniques
(BCTs), as defined in the BCT Taxonomy version 1 [31]. Table
1 lists the BCTs that are delivered to participants in both the
PAAP and WAAP groups, the definition of each BCT according
to the BCT Taxonomy, and the operationalization of each BCT
in the intervention.
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Table 1. Behavior change techniques within the Take Action for Asthma Control intervention (pictorial asthma action plan and written asthma action
plan).
OperationalizationDefinitionBehavior change techniques
The AAPa provides step-by step details of prescription for
asthma medications (eg, 2 puffs twice a day) and help-
seeking steps (eg, call physician).
To prompt detailed planning of performance of the
behavior (must include at least one of the following:
context, frequency, duration, and intensity)
Action planning
The AAP prompts taking medication in the morning and
evening, before exercise (green zone), or in response to
certain symptoms in the yellow and red zones. It also
prompts to call the clinic or hospital or 911 in response to
lack of symptom improvement.
To prompt rehearsal and repetition of the behavior
in the same context repeatedly so that the context
elicits the behavior
Habit formation
The intervention adds an AAP to the family’s home envi-
ronment. Families are encouraged to place the AAP
somewhere easily visible.
To add objects to the environment to facilitate per-
formance of the behavior (more than an information
booklet)
Adding objects to the environment
The AAP provides step-by step details of prescription for
asthma medication and help-seeking steps to follow for
daily asthma management.
To set or agree on a goal defined in terms of the
behavior to be achieved
Goal setting (behavior)
In both the written asthma action plan and pictorial asthma
action plan groups, the physician reviews the AAP during
the clinic appointment.
To present verbal or visual communication from a
credible source in favor of or against the behavior
Credible source
aAAP: asthma action plan.
Procedure
Baseline Visit
Physicians will assess families for study eligibility during their
consultation and invite a researcher to discuss the study further
with interested families. Families who agree to participate will
provide informed consent (parent) and assent (child) and be
randomized to the PAAP or WAAP groups. Group assignment
will then be communicated to the physician, who will generate
a WAAP or a PAAP and deliver the AAP review session with
the family.
Following the AAP review session, the participant and parent
will separately complete brief structured interviews to assess
their comprehension of the new AAP. Participants and parents
will complete a number of questionnaires (see Table 2), and
questions and response options will be read aloud to individuals,
if preferred. Trained researchers will also administer a
standardized measure of reading comprehension and a
pulmonary function test with the participant. All study
documents, including the PAAP and WAAP, will be coded with
the participant’s study ID number to omit identifying
information.
Table 2. Summary of study appointment procedures.
6 month3 month1 monthBaselineAppointment information
ClinicClinicTelephoneClinicLocation
60453090Duration (min)
US $45US $30US $20US $30Gift card value
——
—
b✓aParticipant information
✓✓✓✓Asthma Control Test
✓✓—✓Spirometry
———✓Reading comprehension and health literacy
✓✓—✓AAPc knowledge
✓—✓—AAP satisfaction
✓✓✓✓Daily controller adherenced
aIndicates time points at which data were collected.
bIndicates time points at which data were not collected in relation to a variable, eg, spirometry was not measured at 1 month follow-up as that appointment
was conducted by phone.
cAAP: asthma action plan.
dDaily controller inhaler adherence is monitored continuously through the sensor attached to each participant’s inhaler. Syncing of adherence data with
the sensor dashboard will be checked at 4 time points, but the data will only be discussed with families at the 6-month follow-up appointment.
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To enable the collection of objective adherence data for daily
controller medication, a small electronic sensor will be fitted
to the participant’s inhaler. The sensor is connected to an app
that is downloaded to the participant’s or their parent’s cell
phone or to a device called a hub that can be plugged in at the
family’s home, with individual participant data transferred to
a Web-based dashboard that will be monitored by the research
team. A complimentary canister or diskus (circular, rather than
cylindrical inhaler device) of their daily controller inhaler will
be provided to each participant to allow the research team to fit
the sensor onto the inhaler and to show the family how this is
done for refill medication.
Follow-Up Visits
Table 2 summarizes the procedure and measures at each of the
1-, 3-, and 6-month follow-up visits. In addition to the
procedures outlined in Table 2, during the final study visit, the
data gathered by the adherence sensor will be discussed with
the family. Sensors and hubs will be collected from families,
and each participant will be entered into a lottery for 1 of 6 US
$50 gift cards if the sensor is in working order. See Table 2 for
participant payment information. Finally, families will be invited
to take part in a qualitative interview to provide feedback on
being part of the study and on their AAP.
Measures
To address aims 1 and 3 of this study, validated measures of
health literacy (Short Test of Functional Health Literacy in
Adults [S-TOFHLA]) and numeracy (Asthma Numeracy
Questionnaire [ANQ]), reading comprehension (Wechsler
Individual Achievement Test-III [WIAT-III]), and asthma
symptom control (Asthma Control Test [ACT]) will be used.
Details of the quantitative measurement tools that will be used
are summarized in Table 3. AAP knowledge and AAP
satisfaction will be assessed using a participant and parent
structured interview developed for this study. Asthma symptom
control and adherence to daily controller inhaler will be
measured using objective methods, as described below.
Table 3. Overview of quantitative measures.
RespondentsRange possibleResponse optionsCronbach alpha
according to
previous re-
search
Validation statusLengthMeasure
Literacy assessments
Parents and partic-
ipants aged 13-17
years
0-36Fill in the blanks to
complete sentences
Youth=.90-.92;
adults=.97
Validated for use
with young peo-
ple and adults
aged 13+
36 itemsShort Test of Functional Health
Literacy in Adults
Parents0-4Question-specific;
free text or list of
possible answers
.57aValidated for use
with adults
4 itemsAsthma Numeracy Questionnaire
YouthVaries by grade
—
b>.08Validated for use
based on current
grade
Varies
by
grade
Wechsler Individual Achievement
Test-III
Asthma control
——Version and ques-
tion specific, for ex-
ample, 4-point Lik-
ert scale from very
bad to very good
—Validated for use
with ages 4-11
years and >12
—Asthma Control Test
Parent and youth0-27—.76—7 itemsAge 4-11 years version
Youth5-25—.84—5 itemsAge >12 years version
aFor measures with less than 10 items, an alpha value greater than .05 indicates satisfactory reliability.
b
—: not applicable.
Literacy Assessment
Short Test of Functional Health Literacy in Adults
The S-TOFHLA [32] is a measure of a respondent’s ability to
read and understand health-related information. Total raw scores
<16 are reflective of inadequate literacy. The measure will only
be administered to parents and participants aged 13 to 17 years,
as the measure has been validated in this age group but not with
younger children [29].
Asthma Numeracy Questionnaire
The ANQ [33] is a validated measure assessing understanding
of numerical concepts including risk and percentages in asthma
self-management instructions. This 4-item measure will be
completed by parents at baseline.
Wechsler Individual Achievement Test-III Reading
Comprehension Subtest
The Wechsler Individual Achievement Test-III [34]—Reading
Comprehension Subtest is a measure of reading comprehension
that is widely validated for use in children and adolescents. It
JMIR Res Protoc 2019 | vol. 8 | iss. 6 | e11733 | p. 6https://www.researchprotocols.org/2019/6/e11733/
(page number not for citation purposes)
Hynes et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
will be used as a proxy for health literacy with the full sample
of young people in this study because there are no
comprehension-based health literacy measures for youth aged
less than 13 years. Participants’ raw score on the WIAT-III will
be converted to age-based and grade-based standard scores for
data analyses, and age-based and grade-based percentile rank.
Asthma Symptom Control
The ACT [35] is a measure of asthma health status, including
asthma symptom activity. Both versions of the ACT (aged 4-11
years and >12 years) use the same cutoff score of 19, with lower
scores indicating problems with asthma symptoms. An average
item score will be computed for statistical analyses. Total scores
will be reported for descriptive purposes only.
Asthma Action Plan Knowledge
A structured interview (AAP Knowledge Interview) was designed
for this study and will assess participants’ and parents’
understanding of prescribed AAPs at 3 time points, face-to-face
(baseline and 3 and 6 months). Two versions of this interview
have been created (parent and participant), with 3 parallel forms
of each version (A, B, and C) to reduce practice effects across
assessments. Respondents can refer to their AAP to answer
questions. The first 7 items describe different scenarios
involving asthma symptoms commonly experienced by young
people, and respondents are asked to identify the relevant zone
for each scenario. Each of these items are scored for accuracy
(1=correct, 0=incorrect). The final 3 items ask about details of
the child’s green, yellow, and red zone instructions. Responses
to these final 3 questions are coded for accuracy using the
following categories: 2=correct, 1=correct but vague,
0=incorrect. A total of 3 scores are calculated: (1) zone
identification, (2) treatment plan knowledge, and (3) total score.
Asthma Action Plan Satisfaction
Devised for this study, the AAP Satisfaction Interview consists
of parallel forms (parent and young person), each consisting of
11 items to assess the perception of the content, clarity, appeal,
and utility of AAPs. For example, “How clearly does your (your
child’s) asthma action plan explain medicines that you (your
child) need(s) to take every day?”. Respondents will answer
items using 4-point Likert scales relevant to the wording of each
item (eg, Very helpful to Not helpful at all or Very clear to Not
clear at all), and items are summed to yield a total score. After
each question, respondents will be invited to share feedback or
experiences related to that question.
Pulmonary Function
Pulmonary function will be assessed using spirometry,
administered by a trained member of the research team during
clinic-based appointments. After maximal inhalation, spirometry
measures the volume of air exhaled during a forceful and
complete exhalation, as well as the flow of air at different time
points. The 4 primary endpoints derived and focused on for the
purposes of this study will be (1) the total exhaled volume
known as forced vital capacity (FVC; both absolute and
percentage of predicted values), (2) the volume exhaled in the
first second known as forced expiratory volume in 1 second
(FEV1; both absolute and percentage of predicted values), (3)
their ratio (FEV1/FVC), and (4) the forced expiratory flow
between 25% and 75% of the forced vital capacity (FEF 25-75;
percentage of predicted values), which may provide information
regarding the small airways.
Medication Adherence
Objective adherence data will be collected using an electronic
sensor provided by Propeller Health (Madison, WI), a company
specializing in mobile self-management technology for
respiratory conditions, including asthma. The Propeller Health
sensor provides a reliable and objective record of each actuated
dose from participants’ inhaler [36,37]. During enrollment, the
participant’s treatment plan information will be entered into the
Propeller Health online dashboard, including the type of daily
controller medication, number of puffs per administration (eg,
1 or 2 puffs), frequency of administrations (eg, once or twice
per day), and approximate times per day when they expect to
use the inhaler. Data from the Propeller Health sensor will be
stored on the device and automatically uploaded to the study’s
secure dashboard via a mobile phone app or hub, as previously
described. The dashboard can only be viewed by research and
Propeller Health team members. Participants will not be able
to access their adherence data.
The sensor contains a battery that can last up to 18 months and
can hold up to 1000 pieces of data. Therefore, if the sensor and
app or hub through which it communicates with the Propeller
Health dashboard are not in close proximity for several days, a
sync between the sensor and app or hub will effectively bring
the adherence data up to date. As a result, time away from home
for participants (eg, during vacations or intermittent issues with
Wi-Fi connection) will not detrimentally affect the accurate
collection of adherence data. Once it is time to replace or refill
their inhaler prescription, the family will transfer the sensor to
the participant’s next daily controller inhaler. This transfer can
occur without any disruption to the collection of adherence data.
Before each study visit, the adherence monitoring dashboard
will be checked, and the family will be asked to sync their sensor
with their smartphone app or hub if a sync has not occurred in
recent days.
Families will be asked to have their child use only the inhaler
with the device attached for the duration of the study and that
this device will track particular aspects of medication use.
Reactive effects, if they occur, should be equally distributed
across groups. The outcome of mean daily adherence will be
calculated as the total number of puffs actuated divided by the
total number of puffs prescribed and multiplied by 100. Episodes
of 10 or more actuations in less than a minute will be classified
as dumps (ie, participant’s intentional attempt to appear more
adherent) or device error; such data will be excluded from the
analyses [38].
Feasibility and Acceptability Assessment
To assess the feasibility and acceptability of this pilot RCT,
qualitative data will be collected by reviewing study records,
through interviews with service providers involved in the study
and via exit interviews with a subgroup of participants and
parents. Interviews will be conducted with providers involved
in the study at the beginning and toward the end of the course
of the pilot RCT, either face-to-face or by telephone. Finally,
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semistructured interviews will be conducted with a subgroup
of participants and parents following completion of their
involvement in the study. Exit interviews will be conducted
either face-to-face or by telephone, depending on the availability
and preferences of the interviewees.
The interviews will be conducted by a member of the research
team who is not involved with the day-to-day running of the
study to facilitate openness among the families and providers
to share their study experiences and feedback. Table 4
summarizes the feasibility- and acceptability-related variables
that will be examined in this study, the data collection method
that will be used to gather information related to each variable,
and the schedule for data collection.
Table 4. Feasibility and acceptability outcomes and data collection plan.
ScheduleData collection methodVariable
Feasibility: Is a definitive trial possible? Is it possible to integrate PAAPa within routine care?
Ongoing and 3-month intervalsStudy records and provider interviewsProvider engagement (eg, facilitating and participating
in study meetings)
Ongoing and 3-month intervalsStudy records and interviews with providers
and families
Recruitment and retention rates
3-month intervalsProvider interviewsFit of study activities within clinic workflow
OngoingStudy recordsIntegrity of data collection (eg, missing data)
Exit interviewInterviews with familiesFamily views of study activities (eg, schedule, time
involved, and types of measures)
Exit interviewInterviews with familiesAdequacy of participant payments
Acceptability: Does a PAAP meet the needs of physicians and families?
Providers: 3-month intervals; Families: 1-
month phone interview and exit interview
Interviews with providers and familiesPerceptions of value added to consultations and asthma
management
Providers: 3-month intervals; Families: exit
interview
Interviews with providers and familiesAdequacy of PAAP (eg, accessibility, clarity, usability,
tailoring, liking, and influence)
Providers: 3-month intervals; Families: exit
interview
Interviews with providers and familiesImpact of group assignment on retention
aPAAP: pictorial asthma action plan.
Statistical Analyses
Power Analysis
The aims of the primary quantitative analyses in this pilot RCT
are to assess initial evidence for the efficacy of PAAPs in
comparison with WAAPs for improving pediatric asthma
management and outcomes and to produce robust effect size
estimates ahead of a future definitive RCT. A power analysis
was run for the primary outcome of the ACT using PASS
software version 13 (NCSS, 2019) [39]. Effects were estimated
based on a previous study [40], using WAAP compared with
verbal instruction. Power in this study was calculated for effect
sizes between 0.50 and 1 SD unit increase in the effect size of
the outcome in the treatment group. The group by time
interaction effect (σ=2.21, effect size σm/σ ranged from 0.226
to 0.452) was tested in this power calculation, with alpha set to
.05. In this study, equivalence tests of means (using 2 one-sided
tests on data from a parallel-group design with sample sizes of
25 in the WAAP group and 25 in the PAAP group) will result
in 82% power at a 5.0% significance level when the true
difference between the means is 0.0, the SD is 3.5, and the
equivalence limits are −3.0 and 3.0. Therefore, results that fall
within an SD unit difference would indicate that PAAP is as
good as guideline-recommended care (WAAP) with sufficient
power.
On the basis of our previous research of similar duration, we
anticipate a<20% attrition rate. Thus, we will recruit up to 60
participants from the specialist asthma and pulmonology clinics
within WVU Medicine, with sufficient power to test for
equivalence even with attrition and not accounting for missing
data. In the event of a lower-than-anticipated attrition rate or
data missing completely at random, a sample size of 50 (25 per
group) will maintain high power for detecting equivalence.
Quantitative Data
Preliminary evidence of between-group differences will be
examined in relation to the following outcome variables: AAP
knowledge, AAP satisfaction, ACT scores, mean adherence to
daily controller medication, and pulmonary function using
spirometry. The hypothesis tests of interest will involve the
fixed effects of the time-by-group interaction for all study
outcomes, with covariates included provided they are significant
and improve model fit. Specifically, to account for the
correlation among the repeated measurements on each
participant, general linear mixed models will be the main tools
of analysis for the primary outcomes. These models are designed
to model correlations among observations on subjects (over
time and within groups) and are valid in the presence of missing
at random (MAR) data [41]. Various random effects and
covariance estimates will be compared using the Akaike
Information Criterion to determine the best fitting model.
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Random effects, considering the individual level (rather than
just population) parameters, will be included and may also be
examined in the event of assessing best treatment practices.
Accurate model parameter estimation will be ensured by the
use of the residual maximum likelihood (REML) approach to
estimation (appropriate for use with MAR missing data), and
the Kenward-Roger approximation of the degrees of freedom
will allow for accurate inference.
Given our power to estimate effect sizes for a subsequent
definitive RCT, we will demonstrate the overall stability of the
effect of the treatment response utilizing the F test for
equivalence of the effect of psi-squared, a standardized measure
of difference between groups/time point means and an overall
(across groups and time points) mean. This will be assessed
utilizing output from the best-fitting general linear mixed model
and by testing whether this psi-squared effect size measure falls
in the critical region, following the method outlined by Wang
and Amrhein [42].
SPSS version 24 will be used for data management and basic
analyses; SAS version 9.4 (primarily PROC MIXED) will be
used for all advanced statistical analyses. Every attempt will be
made to minimize attrition and missing data; however, we
recognize that some degree of missing data is inevitable. The
REML method involved in mixed modeling is generally
appropriate for use under the MAR assumption. Moreover, we
will carry out models under missing not at random assumptions
to assess the sensitivity of our conclusions to the missing data
(eg, via selection models or pattern-mixture models, as needed
or appropriate).
Qualitative Data
Thematic analysis will be used to organize and analyze the
qualitative data gathered from providers, participants, and
parents, including AAP satisfaction survey and exit interview
data [43]. The aim of thematic analysis is to facilitate the
identification of patterns of meaning across a qualitative dataset.
Thematic analysis can be used to address a wide range of
research questions and is widely used, increasingly as part of
the processes of development, pilot testing, and evaluation of
behavioral trials [43,44]. Data from interviews with providers
and exit interviews with participants and parents will be
transcribed verbatim and entered into Atlas.ti software for
analysis. Data from the AAP satisfaction survey (1- and 6-month
follow-up) will be transcribed and entered into a Microsoft
Excel database for analysis.
In this study, a theoretical thematic analysis will be conducted
with the aim of addressing the research questions related to the
feasibility and acceptability of the TAAC intervention and study
procedures, as opposed to approaching the data with a more
exploratory aim. Analysis will progress through the phases
recommended by Braun and Clarke [43], including cycles of
repeated reading of transcripts, assigning descriptive codes to
the data, categorizing codes under representative themes,
defining and editing themes, and presenting the report of
findings. All data from provider and exit interviews will be
coded by one member of the research team (LH). A research
assistant will independently code 20% of the provider and exit
interview data, and agreement between coders will be assessed
and discussed. Data from the AAP satisfaction structured
interviews will be analyzed by a research assistant, once a
coding framework is agreed upon between 2 coders (LH and
research assistant).
Results
Recruitment and data collection began in May 2017 and were
completed in October 2018. Results are expected by March
2019.
Discussion
According to the literature, many barriers exist to asthma
self-management among young people, including inadequate
asthma education and knowledge [13]. Although WAAPs are
an evidence-based intervention [3] designed to address these
concerns, many people with asthma are not receiving or utilizing
WAAPs [45] despite national guideline directives [3]. Barriers
to effective asthma self-management may be addressed by the
introduction of more accessible and personalized PAAPs. This
study aims to assess the feasibility and acceptability of the
TAAC intervention and study procedures, for example, the
usability of the PAAP software and appeal of the PAAPs
generated by the software. We also aim to assess whether
literacy and health literacy among children and adolescents and
health literacy in caregivers are associated with asthma
knowledge and health outcomes. We hypothesize that relative
to WAAPs, PAAPs will produce significantly greater
improvements in asthma care knowledge of children and
adolescents and their caregivers, their satisfaction with education
regarding the child’s asthma care and subsequent self-efficacy
for managing symptoms accordingly, asthma health outcomes
(ie, asthma symptom control and pulmonary function), and
adherence to the prescribed medical regimen. It is also
hypothesized that these improvements will occur as a function
of PAAPs having preferred features, such as simplified and
reduced text, lower literacy demand, appealing appearance, and
accessible format and content.
Strengths and Limitations
Notable strengths of this protocol include the mixed-methods
approach to data collection and analysis; integration of
technology in the intervention; use of objective outcomes
measures; identification of BCTs; and the approach of adapting
the standard WAAP, an existing guideline-based tool. The
findings of this study will inform the design of the next phase
of this research, which will be a definitive RCT. Potential
limitations of the protocol are mainly a function of the pilot
nature of the study, including data collection from a small
number of sites, implementation of the intervention by a small
number of physicians, and reliance on Wi-Fi in a rural location
in the United States. Nevertheless, this study will produce
valuable pilot data for a future large-scale definitive trial that
will aim to recruit a large sample from multiple sites and have
substantial potential for national application.
Future Research
The planned feasibility and pilot trial, as part of a larger program
of research, builds on a growing body of innovative AAP
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literature [19-23]. In particular, patient education materials using
a largely pictorial format may also be applicable to people with
other complex conditions, such as type 1 diabetes and cystic
fibrosis. Our future research will include the development of
pictorial tools for diverse populations, including people with a
first language other than English. We will draw on
implementation science frameworks to design and conduct this
research with a view to the adoption of the use of PAAPs in
routine practice.
Acknowledgments
The authors would like to acknowledge the participation of the families involved in this study as well as the clinical teams
supporting the research. The authors also acknowledge the work of BeHealth Solutions, who designed the PAAP software and
will continue to work with this research group on software updates. This project is supported by the Health Resources and Services
Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number R40MC28320, R40
Maternal and Child Health Field-initiated Innovative Research Studies Program. This information or content and conclusions are
those of the authors and should not be construed as the official position or policy of HRSA, HHS, or the US government, nor
should any endorsements be inferred by HRSA, HHS, or the US government.
Conflicts of Interest
None declared.
References
1. Office of Disease Prevention & Health Promotion. Healthy People 2020. Washington, DC: US Department of Health &
Human Services; 2010 Nov 01. Health Communication and Health Information Technology URL:https://www.
healthypeople.gov/2020/topics-objectives/topic/health-communication-and-health-information-technology?topicid=18
[accessed 2018-07-27] [WebCite Cache ID 71D2Iyjiv]
2. Akinbami LJ, Moorman JE, Liu X. Asthma prevalence, health care use, and mortality: United States, 2005-2009. Natl
Health Stat Report 2011 Jan 12(32):1-14 [FREE Full text] [Medline: 21355352]
3. National Heart, Lung, Blood Institute. Guidelines for the Diagnosis and Management of Asthma (EPR-3) URL:https://www.
nhlbi.nih.gov/health-topics/guidelines-for-diagnosis-management-of-asthma [accessed 2018-07-26] [WebCite Cache ID
71D2svqbZ]
4. Bhogal S, Zemek R, Ducharme FM. Written action plans for asthma in children. Cochrane Database Syst Rev
2006(3):CD005306. [doi: 10.1002/14651858.CD005306.pub2] [Medline: 16856090]
5. Ducharme FM, Zemek RL, Chalut D, McGillivray D, Noya FJ, Resendes S, et al. Written action plan in pediatric emergency
room improves asthma prescribing, adherence, and control. Am J Respir Crit Care Med 2011 Jan 15;183(2):195-203. [doi:
10.1164/rccm.201001-0115OC] [Medline: 20802165]
6. Ring N, Jepson R, Hoskins G, Wilson C, Pinnock H, Sheikh A, et al. Understanding what helps or hinders asthma action
plan use: a systematic review and synthesis of the qualitative literature. Patient Educ Couns 2011 Nov;85(2):e131-e143.
[doi: 10.1016/j.pec.2011.01.025] [Medline: 21396793]
7. Douglass J, Aroni R, Goeman D, Stewart K, Sawyer S, Thien F, et al. A qualitative study of action plans for asthma. Br
Med J 2002 Apr 27;324(7344):1003-1005 [FREE Full text] [Medline: 11976240]
8. Sleath B, Carpenter DM, Ayala GX, Williams D, Davis S, Tudor G, et al. Communication during pediatric asthma visits
and child asthma medication device technique 1 month later. J Asthma 2012 Nov;49(9):918-925. [doi:
10.3109/02770903.2012.719250] [Medline: 22974226]
9. Zahran HS, Bailey CM, Damon SA, Garbe PL, Breysse PN. Vital signs: asthma in children - United States, 2001-2016.
MMWR Morb Mortal Wkly Rep 2018 Feb 9;67(5):149-155 [FREE Full text] [doi: 10.15585/mmwr.mm6705e1] [Medline:
29420459]
10. Forbis SG, Aligne CA. Poor readability of written asthma management plans found in national guidelines. Pediatrics 2002
Apr;109(4):e52. [doi: 10.1542/peds.109.4.e52] [Medline: 11927725]
11. Knudson A, Casey M, Burlew M, Davidson G. Disparities in pediatric asthma hospitalizations. J Public Health Manag
Pract 2009;15(3):232-237. [doi: 10.1097/01.PHH.0000349739.81243.ea] [Medline: 19363403]
12. Valet RS, Gebretsadik T, Carroll KN, Wu P, Dupont WD, Mitchel EF, et al. High asthma prevalence and increased morbidity
among rural children in a Medicaid cohort. Ann Allergy Asthma Immunol 2011 Jun;106(6):467-473 [FREE Full text] [doi:
10.1016/j.anai.2011.02.013] [Medline: 21624745]
13. DeWalt DA, Dilling MH, Rosenthal MS, Pignone MP. Low parental literacy is associated with worse asthma care measures
in children. Ambul Pediatr 2007;7(1):25-31 [FREE Full text] [doi: 10.1016/j.ambp.2006.10.001] [Medline: 17261479]
14. Eggleston PA, Malveaux FJ, Butz AM, Huss K, Thompson L, Kolodner K, et al. Medications used by children with asthma
living in the inner city. Pediatrics 1998 Mar;101(3 Pt 1):349-354. [Medline: 9480996]
15. Centers for Disease Control and Prevention. Visual communication resources URL:https://www.cdc.gov/healthliteracy/
developmaterials/visual-communication.html [accessed 2018-07-27] [WebCite Cache ID 71D3Dog5q]
JMIR Res Protoc 2019 | vol. 8 | iss. 6 | e11733 | p. 10https://www.researchprotocols.org/2019/6/e11733/
(page number not for citation purposes)
Hynes et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
16. Barros IM, Alcântara TS, Mesquita AR, Santos AC, Paixão FP, Lyra DP. The use of pictograms in the health care: a
literature review. Res Social Adm Pharm 2014;10(5):704-719. [doi: 10.1016/j.sapharm.2013.11.002] [Medline: 24332470]
17. Houts PS, Doak CC, Doak LG, Loscalzo MJ. The role of pictures in improving health communication: a review of research
on attention, comprehension, recall, and adherence. Patient Educ Couns 2006 May;61(2):173-190. [doi:
10.1016/j.pec.2005.05.004] [Medline: 16122896]
18. Roberts NJ, Evans G, Blenkhorn P, Partridge MR. Development of an electronic pictorial asthma action plan and its use
in primary care. Patient Educ Couns 2010 Jul;80(1):141-146. [doi: 10.1016/j.pec.2009.09.040] [Medline: 19879092]
19. Yin HS, Gupta RS, Mendelsohn AL, Dreyer B, van Schaick L, Brown CR, et al. Use of a low-literacy written action plan
to improve parent understanding of pediatric asthma management: A randomized controlled study. J Asthma 2017
Nov;54(9):919-929. [doi: 10.1080/02770903.2016.1277542] [Medline: 28045551]
20. Burbank AJ, Lewis SD, Hewes M, Schellhase DE, Rettiganti M, Hall-Barrow J, et al. Mobile-based asthma action plans
for adolescents. J Asthma 2015;52(6):583-586 [FREE Full text] [doi: 10.3109/02770903.2014.995307] [Medline: 25494553]
21. Roberts NJ, Mohamed Z, Wong P, Johnson M, Loh L, Partridge MR. The development and comprehensibility of a pictorial
asthma action plan. Patient Educ Couns 2009 Jan;74(1):12-18. [doi: 10.1016/j.pec.2008.07.049] [Medline: 18789626]
22. Yin HS, Dreyer BP, van Schaick L, Foltin GL, Dinglas C, Mendelsohn AL. Randomized controlled trial of a pictogram-based
intervention to reduce liquid medication dosing errors and improve adherence among caregivers of young children. Arch
Pediatr Adolesc Med 2008 Sep;162(9):814-822. [doi: 10.1001/archpedi.162.9.814] [Medline: 18762597]
23. Mitchell SJ, Bilderback AL, Okelo SO. Feasibility of picture-based asthma medication plans in urban pediatric outpatient
clinics. Pediatr Allergy Immunol Pulmonol 2016 Jun 1;29(2):95-99 [FREE Full text] [doi: 10.1089/ped.2016.0640] [Medline:
27583171]
24. Duncan CL, Walker HA, Brabson L, Williford DN, Hynes L, Hogan MB. Developing pictorial asthma action plans to
promote self-management and health in rural youth with asthma: a qualitative study. J Asthma 2017 Sep 21:1-9. [doi:
10.1080/02770903.2017.1371743] [Medline: 28933570]
25. O'Cathain A, Hoddinott P, Lewin S, Thomas KJ, Young B, Adamson J, et al. Maximising the impact of qualitative research
in feasibility studies for randomised controlled trials: guidance for researchers. Pilot Feasibility Stud 2015;1:32 [FREE Full
text] [doi: 10.1186/s40814-015-0026-y] [Medline: 27965810]
26. Eldridge SM, Lancaster GA, Campbell MJ, Thabane L, Hopewell S, Coleman CL, et al. Defining feasibility and pilot
studies in preparation for randomized controlled trials: development of a conceptual framework. PLoS One
2016;11(3):e0150205 [FREE Full text] [doi: 10.1371/journal.pone.0150205] [Medline: 26978655]
27. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions:
Medical Research Council guidance. Br Med J 2015;350:h1258 [FREE Full text] [doi: 10.1136/bmj.h1258] [Medline:
25791983]
28. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, Medical Research Council Guidance. Developing and
evaluating complex interventions: the new Medical Research Council guidance. Br Med J 2008;337:a1655 [FREE Full
text] [doi: 10.1136/bmj.a1655] [Medline: 18824488]
29. Chisolm DJ, Buchanan L. Measuring adolescent functional health literacy: a pilot validation of the Test of Functional
Health Literacy in Adults. J Adolesc Health 2007 Sep;41(3):312-314. [doi: 10.1016/j.jadohealth.2007.04.015] [Medline:
17707303]
30. National Heart, Lung, and Blood Institute. Asthma Action Plan URL:https://www.nhlbi.nih.gov/files/docs/public/lung/
asthma_actplan.pdf [accessed 2019-03-25] [WebCite Cache ID 71D3JhOEg]
31. Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al. The behavior change technique taxonomy
(v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change
interventions. Ann Behav Med 2013 Aug;46(1):81-95. [doi: 10.1007/s12160-013-9486-6] [Medline: 23512568]
32. Baker DW, DeWalt DA, Schillinger D, Hawk V, Ruo B, Bibbins-Domingo K, et al. "Teach to goal": theory and design
principles of an intervention to improve heart failure self-management skills of patients with low health literacy. J Health
Commun 2011;16 Suppl 3:73-88 [FREE Full text] [doi: 10.1080/10810730.2011.604379] [Medline: 21951244]
33. Apter AJ, Cheng J, Small D, Bennett IM, Albert C, Fein DG, et al. Asthma numeracy skill and health literacy. J Asthma
2006 Nov;43(9):705-710. [doi: 10.1080/02770900600925585] [Medline: 17092853]
34. Psychological Corporation. WIAT III: Wechsler Individual Achievement Test, Third Edition. Texas: Psychological
Corporation; 2009.
35. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the asthma control test: a survey
for assessing asthma control. J Allergy Clin Immunol 2004 Jan;113(1):59-65. [doi: 10.1016/j.jaci.2003.09.008] [Medline:
14713908]
36. Barrett M, Combs V, Su JG, Henderson K, Tuffli M, AIR Louisville Collaborative, AIR Louisville Collaborative. AIR
Louisville: addressing asthma with technology, crowdsourcing, cross-sector collaboration, and policy. Health Aff (Millwood)
2018 Dec;37(4):525-534. [doi: 10.1377/hlthaff.2017.1315] [Medline: 29608361]
37. Merchant R, Inamdar R, Henderson K, Barrett M, Su JG, Riley J, et al. Digital health intervention for asthma: patient-reported
value and usability. JMIR Mhealth Uhealth 2018 Jun 4;6(6):e133 [FREE Full text] [doi: 10.2196/mhealth.7362] [Medline:
29866644]
JMIR Res Protoc 2019 | vol. 8 | iss. 6 | e11733 | p. 11https://www.researchprotocols.org/2019/6/e11733/
(page number not for citation purposes)
Hynes et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
38. McQuaid EL, Kopel SJ, Klein RB, Fritz GK. Medication adherence in pediatric asthma: reasoning, responsibility, and
behavior. J Pediatr Psychol 2003;28(5):323-333. [doi: 10.1093/jpepsy/jsg022] [Medline: 12808009]
39. NCSS Statistical Software. URL:https://www.ncss.com/[WebCite Cache ID 778QU30HG]
40. Wong SS, Nathan AM, de Bruyne J, Zaki R, Mohd TS. Does a written asthma action plan reduce unscheduled doctor visits
in children? Indian J Pediatr 2013 Jul;80(7):590-595. [doi: 10.1007/s12098-012-0839-0] [Medline: 22798280]
41. Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. New York: Springer; 2000.
42. Wang F, Amrhein J. Equivalence Tests. In: Proceedings of the SAS®Global Forum 2016. Cary, NC: SAS Institute Inc;
2016 Presented at: SAS®Global Forum 2016; April 18-21, 2016; Las Vegas.
43. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006 Jan;3(2):77-101. [doi:
10.1191/1478088706qp063oa]
44. McEachan RR, Santorelli G, Bryant M, Sahota P, Farrar D, Small N, BiB childhood obesity scientific group. The HAPPY
(Healthy and Active Parenting Programmme for early Years) feasibility randomised control trial: acceptability and feasibility
of an intervention to reduce infant obesity. BMC Public Health 2016 Mar 1;16:211 [FREE Full text] [doi:
10.1186/s12889-016-2861-z] [Medline: 26931491]
45. Camargo CA, Reed CR, Ginde AA, Clark S, Emond SD, Radeos MS. A prospective multicenter study of written action
plans among emergency department patients with acute asthma. J Asthma 2008 Sep;45(7):532-538 [FREE Full text] [doi:
10.1080/02770900801978573] [Medline: 18773321]
Abbreviations
AAP:  asthma action plan
ACT: Asthma Control Test
ANQ: Asthma Numeracy Questionnaire
BCT:  behavior change techniques
EMR:  electronic medical record
FEF 25-75:  forced expiratory flow between 25% and 75% of the forced vital capacity
FEV1:  forced expiratory volume in 1 second
FVC:  Forced Vital Capacity
HHS:  Health and Human Services
HRSA:  Health Resources and Services Administration
MAR:  missing at random
PAAP:  pictorial asthma action plan
RCT:  randomized controlled trial
REML:  residual maximum likelihood
S-TOFHLA:  Short Test of Functional Health Literacy in Adults
TAAC: Take Action for Asthma Control
WAAP:  written asthma action plan
WIAT-III: Wechsler Individual Achievement Test-III
WVU: West Virginia University
Edited by G Eysenbach; submitted 09.08.18; peer-reviewed by E Neter, R van der Vaart; comments to author 16.01.19; revised version
received 09.02.19; accepted 10.02.19; published 17.06.19
Please cite as:
Hynes L, Durkin K, Williford DN, Smith H, Skoner D, Lilly C, Kothari VD, Mc Sharry J, Duncan CL
Comparing Written Versus Pictorial Asthma Action Plans to Improve Asthma Management and Health Outcomes Among Children
and Adolescents: Protocol of a Pilot and Feasibility Randomized Controlled Trial
JMIR Res Protoc 2019;8(6):e11733
URL: https://www.researchprotocols.org/2019/6/e11733/
doi: 10.2196/11733
PMID: 31210140
©Lisa Hynes, Kristine Durkin, Desireé N Williford, Hope Smith, David Skoner, Christa Lilly, Viral Dilip Kothari, Jenny Mc
Sharry, Christina L Duncan. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 17.06.2019.
This is an open-access article distributed under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information,
JMIR Res Protoc 2019 | vol. 8 | iss. 6 | e11733 | p. 12https://www.researchprotocols.org/2019/6/e11733/
(page number not for citation purposes)
Hynes et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
a link to the original publication on http://www.researchprotocols.org, as well as this copyright and license information must be
included.
JMIR Res Protoc 2019 | vol. 8 | iss. 6 | e11733 | p. 13https://www.researchprotocols.org/2019/6/e11733/
(page number not for citation purposes)
Hynes et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
